Find the latest The Biotech Growth Trust PLC (BIOG.L) stock quote, history, news and other vital information to help you with your stock trading and investing.

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings.

The Biotech Growth Trust (BIOG) is managed Geoff Hsu and Josh Golomb at leading global healthcare specialist OrbiMed. The trust provides access to the rapidly evolving biotech sector, seeking ...

The Company notes the announcement on Friday, 1 May 2026 that ARCHIMED has entered into an agreement to acquire BIOG portfolio company, Esperion Therapeutics ("Esperion") for approximately $1 billion, ...

Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. BioGaia ...

The Company notes the announcement on Tuesday, 31 March 2026 that Biogen Inc. ("Biogen") has entered into an agreement to acquire BIOG portfolio company, Apellis Pharmaceuticals, Inc. ("Apellis") for ...

View the latest Biotech Growth Trust PLC (BIOG.UK) stock price, news, historical charts, analyst ratings and financial information from WSJ.

At close: 13 May at 12:59:44 pm GMT+2 ...

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience. To access our Live RNS you must confirm you are a private investor ...

Get the latest Biotech Growth Ord (BIOG.L) stock news and headlines to help you in your trading and investing decisions.

Review the current BioGaia AB Class B (BIOG B:XSTO) dividend yield and history to decide if BIOG B is the best investment for you.